Increased plasma guanylin levels in patients with impaired renal function

Area of Science:

• Endocrinology
• Nephrology
• Gastroenterology

Background:

• Guanylin is a peptide hormone that regulates intestinal fluid and electrolyte transport via the guanylate cyclase C receptor and cyclic GMP.
• The role of the kidney in guanylin metabolism and clearance has not been fully elucidated.

Purpose of the Study:

• To investigate the role of the kidney in the metabolism and elimination of guanylin.
• To assess plasma guanylin concentrations in individuals with varying degrees of renal function.

Main Methods:

• Radioimmunoassay (RIA) was used to measure plasma concentrations of immunoreactive guanylin.
• Plasma samples were collected from three groups: normal individuals, patients with renal disorders (serum creatinine 0.4-11.9 mg/dl), and patients undergoing hemodialysis (HD).
• Guanylin levels were analyzed in relation to serum creatinine, dialysis duration, and hemodialysis membrane type (EVAL vs. PC).

Main Results:

• Plasma guanylin concentrations were significantly correlated with serum creatinine levels in non-HD patients (r=0.81, p<0.0001).
• In HD patients, plasma guanylin levels correlated with dialysis duration (r=0.63, p<0.01) and decreased after HD using EVAL membranes, but not PC membranes.
• Ten kilodalton guanylin was identified as the main component in plasma and hemofiltrates of HD patients.

Conclusions:

• The kidney plays a significant role in the elimination and/or metabolism of guanylin.
• Impaired kidney function leads to elevated plasma guanylin levels.
• Hemodialysis, particularly with EVAL membranes, can reduce plasma guanylin concentrations, supporting the kidney's role in its clearance.